Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $5.65 and traded as low as $5.29. Hypera shares last traded at $5.33, with a volume of 945 shares changing hands.
Hypera Stock Performance
The company has a market capitalization of $3.14 billion, a PE ratio of 9.05 and a beta of 1.04. The firm’s 50-day simple moving average is $5.24 and its 200 day simple moving average is $5.65.
Hypera (OTCMKTS:HYPMY – Get Free Report) last announced its quarterly earnings data on Thursday, July 25th. The company reported $0.15 EPS for the quarter. The company had revenue of $420.00 million during the quarter.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Further Reading
- Five stocks we like better than Hypera
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- The Role Economic Reports Play in a Successful Investment Strategy
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What is the Australian Securities Exchange (ASX)
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
